Birdwatch Note
2024-09-24 16:15:51 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
新型コロナワクチンは、WHO,米CDC,欧EMA他、世界各先進国の専門家集団に一致して推奨されています。 https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/safety-of-vaccines.html https://www.ema.europa.eu/en/human-regulatory-overview/public-health-threats/coronavirus-disease-covid-19/covid-19-medicines/safety-covid-19-vaccines#:~:text=The%20safety%20profiles%20of%20the,few%20of%20these%20rare%20cases. 下記15p https://www.mhlw.go.jp/content/10900000/001172481.pdf その有効性は、画像中の何のエビデンスでもない話↓と違い https://medical.nikkeibp.co.jp/leaf/all/cancernavi/series/kenkyu/201905/560545.html と違いオミクロン期のメタアナリシスでも確認され、 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00409-1/fulltext WHOに下記にまとめられたように世界の数百もの研究で確認され続けています。 https://view-hub.org/sites/default/files/2024-05/COVID19%20VE%20Studies_Forest%20Plots_Omicron.pdf 安全性も各国の医療データベースを使った無数の研究でモニタリングされ、推奨の妨げになるような看過できないリスクは一貫した検出をできていないため、上記のような世界中の推奨になっています。 https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/safety-of-vaccines.html https://www.ema.europa.eu/en/human-regulatory-overview/public-health-threats/coronavirus-disease-covid-19/covid-19-medicines/safety-covid-19-vaccines#:~:text=The%20safety%20profiles%20of%20the,few%20of%20these%20rare%20cases.
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1838588313093181624
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1838613326181670946
- noteId - 1838613326181670946
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1727194551403
- tweetId - 1838588313093181624
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 新型コロナワクチンは、WHO,米CDC,欧EMA他、世界各先進国の専門家集団に一致して推奨されています。 https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/safety-of-vaccines.html https://www.ema.europa.eu/en/human-regulatory-overview/public-health-threats/coronavirus-disease-covid-19/covid-19-medicines/safety-covid-19-vaccines#:~:text=The%20safety%20profiles%20of%20the,few%20of%20these%20rare%20cases. 下記15p https://www.mhlw.go.jp/content/10900000/001172481.pdf その有効性は、画像中の何のエビデンスでもない話↓と違い https://medical.nikkeibp.co.jp/leaf/all/cancernavi/series/kenkyu/201905/560545.html と違いオミクロン期のメタアナリシスでも確認され、 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00409-1/fulltext WHOに下記にまとめられたように世界の数百もの研究で確認され続けています。 https://view-hub.org/sites/default/files/2024-05/COVID19%20VE%20Studies_Forest%20Plots_Omicron.pdf 安全性も各国の医療データベースを使った無数の研究でモニタリングされ、推奨の妨げになるような看過できないリスクは一貫した検出をできていないため、上記のような世界中の推奨になっています。 https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/safety-of-vaccines.html https://www.ema.europa.eu/en/human-regulatory-overview/public-health-threats/coronavirus-disease-covid-19/covid-19-medicines/safety-covid-19-vaccines#:~:text=The%20safety%20profiles%20of%20the,few%20of%20these%20rare%20cases.
Note Ratings
rated at | rated by | |
2024-09-25 17:17:49 -0500 | Rating Details | |
2024-09-25 07:57:48 -0500 | Rating Details | |
2024-09-25 07:06:22 -0500 | Rating Details | |
2024-09-25 06:04:19 -0500 | Rating Details | |
2024-09-25 05:40:51 -0500 | Rating Details | |
2024-09-25 03:27:08 -0500 | Rating Details | |
2024-09-25 03:21:04 -0500 | Rating Details | |
2024-09-25 03:07:56 -0500 | Rating Details | |
2024-09-25 01:18:39 -0500 | Rating Details | |
2024-09-25 01:09:27 -0500 | Rating Details | |
2024-09-24 23:21:49 -0500 | Rating Details | |
2024-09-24 23:04:05 -0500 | Rating Details | |
2024-09-24 22:55:21 -0500 | Rating Details | |
2024-09-24 22:26:06 -0500 | Rating Details | |
2024-09-24 22:03:03 -0500 | Rating Details | |
2024-09-24 21:56:29 -0500 | Rating Details | |
2024-09-24 21:47:50 -0500 | Rating Details | |
2024-09-24 21:22:52 -0500 | Rating Details | |
2024-09-24 21:21:37 -0500 | Rating Details | |
2024-09-24 20:59:00 -0500 | Rating Details | |
2024-09-24 20:51:37 -0500 | Rating Details | |
2024-09-24 20:35:38 -0500 | Rating Details | |
2024-09-24 19:37:12 -0500 | Rating Details | |
2024-09-24 19:32:07 -0500 | Rating Details | |
2024-09-24 19:17:13 -0500 | Rating Details | |
2024-09-24 18:45:51 -0500 | Rating Details | |
2024-09-24 18:34:46 -0500 | Rating Details | |
2024-09-24 18:31:03 -0500 | Rating Details | |
2024-09-24 18:06:43 -0500 | Rating Details | |
2024-09-24 18:06:11 -0500 | Rating Details | |
2024-09-24 17:57:53 -0500 | Rating Details | |
2024-09-24 17:49:47 -0500 | Rating Details | |
2024-09-24 17:44:32 -0500 | Rating Details | |
2024-09-24 17:39:59 -0500 | Rating Details | |
2024-09-24 17:32:15 -0500 | Rating Details | |
2024-09-24 17:19:33 -0500 | Rating Details | |
2024-09-24 17:18:51 -0500 | Rating Details | |
2024-09-24 17:16:44 -0500 | Rating Details | |
2024-09-24 17:15:31 -0500 | Rating Details | |
2024-09-24 17:13:37 -0500 | Rating Details | |
2024-09-24 17:13:06 -0500 | Rating Details | |
2024-09-24 17:08:25 -0500 | Rating Details | |
2024-09-24 16:54:22 -0500 | Rating Details | |
2024-09-24 16:44:22 -0500 | Rating Details | |
2024-09-24 16:30:06 -0500 | Rating Details | |
2024-09-24 16:17:31 -0500 | Rating Details | |
2024-09-24 16:13:32 -0500 | Rating Details | |
2024-09-24 16:11:33 -0500 | Rating Details | |
2024-09-24 15:51:42 -0500 | Rating Details | |
2024-09-24 15:47:08 -0500 | Rating Details | |
2024-09-24 15:46:49 -0500 | Rating Details | |
2024-09-24 14:22:30 -0500 | Rating Details | |
2024-09-24 13:36:41 -0500 | Rating Details | |
2024-09-24 13:32:12 -0500 | Rating Details | |
2024-09-24 12:58:55 -0500 | Rating Details | |
2024-09-24 12:57:50 -0500 | Rating Details | |
2024-09-24 12:55:50 -0500 | Rating Details | |
2024-09-24 12:41:40 -0500 | Rating Details | |
2024-09-24 12:30:32 -0500 | Rating Details | |
2024-09-24 12:27:15 -0500 | Rating Details | |
2024-09-24 12:27:14 -0500 | Rating Details | |
2024-09-24 12:24:21 -0500 | Rating Details | |
2024-09-24 12:19:43 -0500 | Rating Details | |
2024-09-24 11:47:24 -0500 | Rating Details | |
2024-09-25 05:36:26 -0500 | Rating Details | |
2024-09-25 02:21:50 -0500 | Rating Details |